Wall Street Zen Upgrades Cibus (NASDAQ:CBUS) to Hold

Cibus (NASDAQ:CBUS) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.

Separately, Weiss Ratings lowered shares of Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, June 29th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $9.00.

Cibus Stock Performance

NASDAQ CBUS opened at $1.70 on Friday. Cibus has a 52-week low of $1.09 and a 52-week high of $4.19. The company has a 50-day simple moving average of $1.50 and a 200 day simple moving average of $1.97. The company has a market capitalization of $129.76 million, a PE ratio of -0.86 and a beta of 1.65.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The company had revenue of $1.68 million during the quarter, compared to the consensus estimate of $1.61 million. Cibus had a negative return on equity of 200.87% and a negative net margin of 2,366.33%. As a group, analysts forecast that Cibus will post -1.05 EPS for the current fiscal year.

Institutional Investors Weigh In On Cibus

A number of hedge funds and other institutional investors have recently bought and sold shares of CBUS. Weiss Asset Management LP bought a new stake in Cibus during the 1st quarter valued at $1,758,000. Geode Capital Management LLC boosted its holdings in shares of Cibus by 4.7% in the fourth quarter. Geode Capital Management LLC now owns 275,180 shares of the company’s stock worth $479,000 after acquiring an additional 12,467 shares during the period. Certior Financial Group LLC grew its position in shares of Cibus by 46.7% in the fourth quarter. Certior Financial Group LLC now owns 271,164 shares of the company’s stock valued at $472,000 after purchasing an additional 86,378 shares in the last quarter. Prescott Group Capital Management L.L.C. purchased a new position in shares of Cibus in the fourth quarter valued at $345,000. Finally, Jane Street Group LLC bought a new stake in shares of Cibus during the 2nd quarter valued at $207,000. Institutional investors own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.